Single-Cell RNA Sequencing for Studying Human Cancers.

Area of Science:

• Oncology
• Genomics
• Bioinformatics

Background:

• Single-cell RNA sequencing (scRNA-seq) has seen extensive application in cancer biology over the past decade.
• Thousands of scRNA-seq studies have been published across numerous cancer types and study designs.
• scRNA-seq has significantly improved understanding of tumor biology, the tumor microenvironment, and therapeutic responses.

Purpose of the Study:

• To review the advancements in cancer biology driven by scRNA-seq technology.
• To discuss the computational challenges specific to applying scRNA-seq in cancer research.
• To highlight the potential of scRNA-seq in clinical decision-making.

Main Methods:

• Review of published scRNA-seq datasets and studies in cancer biology.
• Analysis of computational methodologies and analytical pipelines used in scRNA-seq research.
• Identification of data science tools applied for extracting insights from scRNA-seq data.

Main Results:

• scRNA-seq has provided unprecedented insights into tumor heterogeneity and cellular dynamics.
• The technology has elucidated complex interactions within the tumor microenvironment.
• scRNA-seq data is increasingly informing therapeutic strategies and response predictions.

Conclusions:

• scRNA-seq is a transformative technology in cancer research, with growing clinical relevance.
• Addressing computational challenges is crucial for maximizing the potential of scRNA-seq in oncology.
• Continued development of analytical tools will further enhance discoveries in cancer biology.